Skip to main content

Table 3 Main effects of topical calcineurin inhibitors compared to topical corticosteroids

From: Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)

Parameter

Topical Pimecrolimus (810 Da)

Topical Tacrolimus (822 Da)

Topical Corticosteroids (<500 Da)

Activity on cells

T Lymphocytes, Mast cells,

T Lymphocytes, Mast cells, Eosinophils, Basophils, Langherans cells,

T Lymphocytes, Mast cells, Eosinophils, Basophils, Langherans cells, Keratinocytes, Endothelial cells, Fibroblasts

Cytokines

IL-2, IL-3, IL-4, IL-5,IL-13,IL-33, TNF-α, INF-γ, GM-CSF

IL-2, IL-3, IL-4, IL-5,IL-13,IL-31,IL-33, TNF-α, INF-γ, GM-CSF

IL-1,IL-2, IL-3, IL-4, IL-5,IL-6, IL-13,IL-31,TNF-α, INF-γ, GM-CSF,TSLP

Inhibition function and Apoptosis of Langherans cells

-

+

++

Absorption through the skin

+

++

+++

Atrophogenic activity

-

-

+++